SCHULTES BIRGIT C (EVP, Chief Scientific Officer) received a stock award from INTELLIA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2025ACC: 0000950170-25-032101
Officer· EVP, Chief Scientific Officer
Since Mar 2026
+91.31K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
91.31K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+37.60K
Price / share
—
Trade value
—
% of position
55.6%
3/1/2025
67.61K→105.22K
Total
Net shares
+37.60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | A · Award | +37.60K | — | — | 55.6% | 67.61K | 105.22K |
| Total | +37.60K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
53.71K shares
Shares
+53.71K
Strike price
10.09
Held after
53.71K
Exercisable
—
3/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock53.71K shares | 3/1/2025 | A · Award | +53.71K | 10.09 | — | 53.71K |